THC BioMed Intl Ltd. announced that it has been granted a licence by an overseas government to cultivate cannabis for medical and scientific use. These studies show that CBD might help prime cells against COVID. Further testing and peer review are required and intend to be leaders in that effort.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -.--% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.4M | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |
- Stock Market
- Equities
- THC Stock
- News THC Biomed Intl Ltd.
- THC Biomed Intl Ltd. Grants Licence by Overseas Government to Cultivate Cannabis for Medical and Scientific Use